Showing results (2131-2140 of 3,783) with videos related to

Sort By:
Pageof 379
Urology|August 30, 2000
Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE databaseG D Grossfeld, J J Chang, J M Broering, et al.
Cancer Research|April 15, 2000
Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancerM P Ebert, T Günther, J Hoffmann, et al.
The American Journal of Gastroenterology|April 24, 2001
Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal diseaseS Miehlke, J Yu, M Schuppler, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 31, 2019
[Influence of antiretroviral prophylaxis on growth of HIV-exposed uninfected infants]F Hu, J J Lu, J J Liang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 31, 2019
[Evaluation of CT angiography vascular localization combined with refined three-dimensional printing in guiding the resection and reconstruction of complex oral cancer]S C Gao, H Tian, J J Yu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 1, 1999
Factors related to delayed treatment and posttreatment symptom severity in Taiwanese patients with benign prostatic hyperplasiaC K Chang, H J Yu, K W Chan, et al.
Oncogene|December 16, 2014
The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathwayL Wang, G Song, X Chang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entryKelly J Yu, Arman Bashirova, Margaret M Madeleine, et al.
Journal of Clinical Pharmacy and Therapeutics|May 25, 2013
Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimizationG Cao, J Zhang, X Wu, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2014
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trialsP Schoenfeld, M Pimentel, L Chang, et al.
Pageof 379